Cognes Granted U.S. Patent for AI-Powered Early Dementia Detection Platform
Stockholm, Sweden – June 2024 – Cognes Medical Solutions has been granted a U.S. patent for its AI-powered dementia detection platform, marking a significant step toward revolutionizing early diagnosis and care for neurodegenerative diseases. The patented solution analyzes facial features using machine learning to identify early signs of cognitive decline. Delivered via a smartphone app, […]
Cognes Granted U.S. Patent for AI-Powered Early Dementia Detection Platform Read More »